Related Articles
Elevated CD44 expression predicts poor prognosis in patients with low‑grade glioma
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Prognostic factors of long‑term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12‑year experience from a single center
Worst pattern of invasion and other histopathological features in oral cancer as determinants of prognosis and survival rate: A retrospective cohort analysis
Toll‑like receptor 4 and its associated proteins as prognostic factors for HCC treated by post‑radiotherapy surgery